Heart Rate Monitoring by Wearable Devices in Graves' Disease
Graves' Disease in Remission (Disorder)
About this trial
This is an interventional diagnostic trial for Graves' Disease in Remission (Disorder)
Eligibility Criteria
Inclusion Criteria:
- Patients with Graves' disease who are being treated with anti-thyroid drugs (ATDs) and planned to discontinue ATDs
- Those who have who have continued to administer ATDs for more than 1 year
- Those who showed normal findings on thyroid function tests while maintaining stable doses of ATDs in the last 3 months
- Those who can use wearable devices and smartphone apps to work with during the research period
Exclusion Criteria:
- Those with heart disease, such as arrhythmia, that can affect heart rate
- Those who are taking medications that may affect their heart rate
- Those who researchers deemed unsuitable for participation
Sites / Locations
- Chungbuk National University Hospital
- Chung-Ang University Hospital
- Eulji University Nowon Eulji Medical Center
- Korea University Guro Hospital
- Seoul National University Hospital
- The Catholic University of Korea Eunpyeong St. Mary's Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
No Intervention
No Intervention
Wearable device group
Control group 1
Control group 2
Participants use wearable device and their heart rate and activity are monitored. If their resting heart rate (rHR) increase beyond the set range or they have hyperthyroid symptoms and signs, they should come to the hospital and get tests for thyroid function. If their rHR stay within set range and they have no symptoms and signs, they come to hospital and get tests for thyroid function 6 months after discontinuing anti-thyroid drugs.
articipants don't use wearable devices. If they have hyperthyroid symptoms and signs, they should come to the hospital and get tests for thyroid function. If they have no symptoms and signs, they come to hospital and get tests for thyroid function 6 months after discontinuing anti-thyroid drugs.
Participants don't use wearable devices. If they have hyperthyroid symptoms and signs, they should come to the hospital and get tests for thyroid function. If they have no symptoms and signs, they come to hospital and get tests for thyroid function 3 and 6 months after discontinuing anti-thyroid drugs.